Torensma R - Search Results

1

Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses.

de Vries IJ, Tel J, Benitez-Ribas D, Torensma R, Figdor CG. de Vries IJ, et al. Among authors: torensma r. Mol Immunol. 2011 Mar;48(6-7):810-7. doi: 10.1016/j.molimm.2010.12.022. Epub 2011 Jan 22. Mol Immunol. 2011. PMID: 21257206

2

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.

Tacken PJ, de Vries IJ, Torensma R, Figdor CG. Tacken PJ, et al. Among authors: torensma r. Nat Rev Immunol. 2007 Oct;7(10):790-802. doi: 10.1038/nri2173. Nat Rev Immunol. 2007. PMID: 17853902 Review.

3

IL-4 and IL-13 alter plasmacytoid dendritic cell responsiveness to CpG DNA and herpes simplex virus-1.

Tel J, Torensma R, Figdor CG, de Vries IJ. Tel J, et al. Among authors: torensma r. J Invest Dermatol. 2011 Apr;131(4):900-6. doi: 10.1038/jid.2010.410. Epub 2010 Dec 30. J Invest Dermatol. 2011. PMID: 21191414 Free article.

4

The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues.

Tel J, Hato SV, Torensma R, Buschow SI, Figdor CG, Lesterhuis WJ, de Vries IJ. Tel J, et al. Among authors: torensma r. Cancer Immunol Immunother. 2012 Jul;61(7):1101-11. doi: 10.1007/s00262-011-1189-x. Epub 2011 Dec 23. Cancer Immunol Immunother. 2012. PMID: 22193989 Free PMC article.

5

Harnessing human plasmacytoid dendritic cells as professional APCs.

Tel J, van der Leun AM, Figdor CG, Torensma R, de Vries IJ. Tel J, et al. Among authors: torensma r. Cancer Immunol Immunother. 2012 Aug;61(8):1279-88. doi: 10.1007/s00262-012-1210-z. Cancer Immunol Immunother. 2012. PMID: 22294456 Free PMC article. Review.

6

Antibodies and carbohydrate ligands binding to DC-SIGN differentially modulate receptor trafficking.

Tacken PJ, Ter Huurne M, Torensma R, Figdor CG. Tacken PJ, et al. Among authors: torensma r. Eur J Immunol. 2012 Aug;42(8):1989-98. doi: 10.1002/eji.201142258. Eur J Immunol. 2012. PMID: 22653683 Free article.

7

The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells.

Cambi A, Gijzen K, de Vries lJ, Torensma R, Joosten B, Adema GJ, Netea MG, Kullberg BJ, Romani L, Figdor CG. Cambi A, et al. Among authors: torensma r. Eur J Immunol. 2003 Feb;33(2):532-8. doi: 10.1002/immu.200310029. Eur J Immunol. 2003. PMID: 12645952 Free article.

8

Analysis of dendritic cell trafficking using EGFP-transgenic mice.

Eggert AA, van der Voort R, Torensma R, Moulin V, Boerman OC, Oyen WJ, Punt CJ, Diepstra H, de Boer AJ, Figdor CG, Adema GJ. Eggert AA, et al. Among authors: torensma r. Immunol Lett. 2003 Oct 9;89(1):17-24. doi: 10.1016/s0165-2478(03)00105-6. Immunol Lett. 2003. PMID: 12946860

9

Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients.

de Vries IJ, Lesterhuis WJ, Scharenborg NM, Engelen LP, Ruiter DJ, Gerritsen MJ, Croockewit S, Britten CM, Torensma R, Adema GJ, Figdor CG, Punt CJ. de Vries IJ, et al. Among authors: torensma r. Clin Cancer Res. 2003 Nov 1;9(14):5091-100. Clin Cancer Res. 2003. PMID: 14613986

10

Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody.

Tacken PJ, de Vries IJ, Gijzen K, Joosten B, Wu D, Rother RP, Faas SJ, Punt CJ, Torensma R, Adema GJ, Figdor CG. Tacken PJ, et al. Among authors: torensma r. Blood. 2005 Aug 15;106(4):1278-85. doi: 10.1182/blood-2005-01-0318. Epub 2005 May 5. Blood. 2005. PMID: 15878980 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters